Marika Sarfati - Publications

Affiliations: 
Université de Montréal, Montréal, Canada 
Area:
Microbiology Biology, Immunology, Cell Biology

136 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Bsat M, Mehta H, Rubio M, Sarfati M. The Conversion of Human Tissue-Like Inflammatory Monocytes Into Macrophages. Current Protocols. 1: e74. PMID 33705607 DOI: 10.1002/cpz1.74  0.319
2021 Mehta H, Mashiko S, Angsana J, Rubio M, Hsieh YM, Maari C, Reich K, Blauvelt A, Bissonnette R, Muñoz-Elías EJ, Sarfati M. Differential Changes in Inflammatory Mononuclear Phagocyte and T Cell Profiles within Psoriatic Skin during Treatment with Guselkumab versus Secukinumab. The Journal of Investigative Dermatology. PMID 33524368 DOI: 10.1016/j.jid.2021.01.005  0.543
2020 Bsat M, Chapuy L, Rubio M, Sarfati M. A two-step human culture system replicates intestinal monocyte maturation cascade: conversion of tissue-like inflammatory monocytes into macrophages. European Journal of Immunology. PMID 32557554 DOI: 10.1002/Eji.202048555  0.572
2020 Chapuy L, Sarfati M. Single-Cell Protein and RNA Expression Analysis of Mononuclear Phagocytes in Intestinal Mucosa and Mesenteric Lymph Nodes of Ulcerative Colitis and Crohn's Disease Patients. Cells. 9. PMID 32230977 DOI: 10.3390/Cells9040813  0.409
2020 Leyva-Castillo JM, Galand C, Mashiko S, Bissonnette R, McGurk A, Ziegler SF, Dong C, McKenzie ANJ, Sarfati M, Geha RS. ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation. The Journal of Allergy and Clinical Immunology. PMID 32179159 DOI: 10.1016/J.Jaci.2020.02.026  0.466
2019 Chapuy L, Bsat M, Sarkizova S, Rubio M, Therrien A, Wassef E, Bouin M, Orlicka K, Weber A, Hacohen N, Villani AC, Sarfati M. Correction: Two distinct colonic CD14 subsets characterized by single-cell RNA profiling in Crohn's disease. Mucosal Immunology. PMID 31819171 DOI: 10.1038/S41385-019-0242-5  0.42
2019 Mashiko S, Edelmayer RM, Bi Y, Olson LM, Wetter JB, Wang J, Maari C, Saint-Cyr Proulx E, Kaimal V, Li X, Salte K, Garcet S, Kannan AK, Huang SM, Cao X, ... ... Sarfati M, et al. Persistence of inflammatory phenotype in residual psoriatic plaques in patients on effective biologic therapy: Residual Psoriatic Plaques After Treatment. The Journal of Investigative Dermatology. PMID 31715177 DOI: 10.1016/J.Jid.2019.09.027  0.477
2019 Pramil E, Herbi Bastian L, Denèfle T, Nemati F, Xiao M, Lardé E, Maloum K, Roos-Weil D, Chapiro E, Le Garff-Tavernier M, Davi F, Decaudin D, Sarfati M, Nguyen-Khac F, Merle-Béral H, et al. Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1-derived peptides overcomes drug resistance. Blood Advances. 3: 2920-2933. PMID 31648314 DOI: 10.1182/Bloodadvances.2019000350  0.408
2019 Chapuy L, Bsat M, Rubio M, Harvey F, Motta V, Schwenter F, Wassef R, Richard C, Deslandres C, Nguyen BN, Soucy G, Hacohen N, Fritz J, Villani AC, Mehta H, ... Sarfati M, et al. Transcriptomic analysis and High dimensional phenotypic mapping of mononuclear phagocytes in mesenteric lymph nodes reveal differences between ulcerative colitis and Crohn's disease. Journal of Crohn's & Colitis. PMID 31541232 DOI: 10.1093/Ecco-Jcc/Jjz156  0.411
2019 Chapuy L, Bsat M, Rubio M, Sarkizova S, Therrien A, Bouin M, Orlicka K, Weber A, Soucy G, Villani AC, Sarfati M. IL-12 and mucosal CD14+ monocyte-like cells induce IL-8 in colonic memory CD4+ T cells of patients with Ulcerative colitis but not Crohn's disease. Journal of Crohn's & Colitis. PMID 31206576 DOI: 10.1093/Ecco-Jcc/Jjz115  0.638
2019 Bsat M, Chapuy L, Rubio M, Wassef R, Richard C, Schwenter F, Loungnarath R, Soucy G, Mehta H, Sarfati M. Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients. Frontiers in Immunology. 10: 1177. PMID 31191543 DOI: 10.3389/Fimmu.2019.01177  0.585
2019 Chapuy L, Bsat M, Sarkizova S, Rubio M, Therrien A, Wassef E, Bouin M, Orlicka K, Weber A, Hacohen N, Villani AC, Sarfati M. Two distinct colonic CD14 subsets characterized by single-cell RNA profiling in Crohn's disease. Mucosal Immunology. PMID 30670762 DOI: 10.1038/S41385-018-0126-0  0.606
2019 Mehta H, Mashiko S, Angsana J, Maari C, Bissonnette R, Sarfati M, Muñoz EJ. LB1143 New insights into the role of T cells in psoriasis: Identification of multi-cytokine producing T cell subsets and a skewed relative contribution of IL17A production by tissue resident CD103+CD8+ T cells Journal of Investigative Dermatology. 139. DOI: 10.1016/J.Jid.2019.06.116  0.547
2018 Therrien A, Chapuy L, Bsat M, Rubio M, Bernard G, Arslanian E, Orlicka K, Weber A, Panzini BP, Dorais J, Bernard EJ, Soucy G, Bouin M, Sarfati M. Recruitment of Activated Neutrophils Correlates with Disease Severity in Adult Crohn's Disease. Clinical and Experimental Immunology. PMID 30347439 DOI: 10.1111/Cei.13226  0.471
2018 Cabon L, Bertaux A, Brunelle-Navas MN, Nemazanyy I, Scourzic L, Delavallée L, Vela L, Baritaud M, Bouchet S, Lopez C, Quang Van V, Garbin K, Chateau D, Gilard F, Sarfati M, et al. AIF loss deregulates hematopoiesis and reveals different adaptive metabolic responses in bone marrow cells and thymocytes. Cell Death and Differentiation. PMID 29323266 DOI: 10.1038/S41418-017-0035-X  0.341
2017 Mehta H, Goulet PO, Mashiko S, Desjardins J, Pérez G, Koenig M, Senécal JL, Constante M, Santos MM, Sarfati M. Early life antibiotic exposure causes intestinal dysbiosis and exacerbates skin and lung pathology in experimental systemic sclerosis. The Journal of Investigative Dermatology. PMID 28757138 DOI: 10.1016/J.Jid.2017.06.019  0.393
2017 Mashiko S, Mehta H, Bissonnette R, Sarfati M. Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis. Journal of Dermatological Science. PMID 28743611 DOI: 10.1016/J.Jdermsci.2017.07.003  0.47
2017 Jack C, Mashiko S, Arbour N, Bissonnette R, Sarfati M. Persistence of interleukin (IL)-17A+ T lymphocytes and IL-17A expression in treatment-resistant psoriatic plaques despite ustekinumab therapy. The British Journal of Dermatology. 177: 267-270. PMID 27599204 DOI: 10.1111/Bjd.15029  0.451
2016 Mehta H, Goulet PO, Nguyen V, Pérez G, Koenig M, Senécal JL, Sarfati M. Topoisomerase I peptide-loaded dendritic cells induce autoantibody response as well as skin and lung fibrosis. Autoimmunity. 1-11. PMID 27808577 DOI: 10.1080/08916934.2016.1230848  0.338
2016 Bissonnette R, Fuentes-Duculan J, Mashiko S, Li X, Bonifacio KM, Cueto I, Suárez-Fariñas M, Maari C, Bolduc C, Nigen S, Sarfati M, Krueger JG. Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway. Journal of Dermatological Science. PMID 27743912 DOI: 10.1016/J.Jdermsci.2016.09.019  0.355
2016 Randolph G, Colonna M, Choi J, Mehandru S, Ancuta P, Sarfati M, Cohen E, Epelman S, Robbins C, Cybulsky M. Cheolho Cheong (1974–2016) Cell Metabolism. 24: 187-188. DOI: 10.1016/J.Cmet.2016.07.019  0.33
2015 Duerr CU, McCarthy CD, Mindt BC, Rubio M, Meli AP, Pothlichet J, Eva MM, Gauchat JF, Qureshi ST, Mazer BD, Mossman KL, Malo D, Gamero AM, Vidal SM, King IL, ... Sarfati M, et al. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nature Immunology. PMID 26595887 DOI: 10.1038/Ni.3308  0.438
2015 Sarfati M, Wakahara K, Chapuy L, Delespesse G. Mutual Interaction of Basophils and T Cells in Chronic Inflammatory Diseases. Frontiers in Immunology. 6: 399. PMID 26284078 DOI: 10.3389/Fimmu.2015.00399  0.437
2015 Bsat M, Chapuy L, Baba N, Rubio M, Panzini B, Wassef R, Richard C, Soucy G, Mehta H, Sarfati M. Differential accumulation and function of proinflammatory 6-sulfo LacNAc dendritic cells in lymph node and colon of Crohn's versus ulcerative colitis patients. Journal of Leukocyte Biology. PMID 26162403 DOI: 10.1189/Jlb.5A1014-509Rr  0.531
2015 Mashiko S, Bouguermouh S, Rubio M, Baba N, Bissonnette R, Sarfati M. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. The Journal of Allergy and Clinical Immunology. 136: 351-359.e1. PMID 25792465 DOI: 10.1016/J.Jaci.2015.01.033  0.528
2015 Martinez-Torres AC, Quiney C, Attout T, Boullet H, Herbi L, Vela L, Barbier S, Chateau D, Chapiro E, Nguyen-Khac F, Davi F, Le Garff-Tavernier M, Moumné R, Sarfati M, Karoyan P, et al. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans. Plos Medicine. 12: e1001796. PMID 25734483 DOI: 10.1371/Journal.Pmed.1001796  0.482
2014 Grelier A, Le Garff-Tavernier M, Nauwelaers F, Sarfati M, Merle-Beral H. Soluble CD23 measurement by CBA: A convenient and reliable quantification method in chronic lymphocytic leukemia Cytometry Part B - Clinical Cytometry. 86: 91-97. PMID 24150841 DOI: 10.1002/Cyto.B.21135  0.366
2014 Farren TW, Liu F, Le Garff-Tavernier M, Sarfati M, Nauwelaers F, Keenan J, Warner N, Merle-Beral H, Agrawal SG. Soluble CD23 (sCD23): A Forgotten Indicator of Prognosis and Identifier of Outcome in Patients with Chronic Lymphocytic Leukemia Utilizing a Novel Cba Approach Blood. 124: 1949-1949. DOI: 10.1182/Blood.V124.21.1949.1949  0.318
2013 Baba N, Van VQ, Wakahara K, Rubio M, Fortin G, Panzini B, Soucy G, Wassef R, Richard C, Tamaz R, Lahaie R, Bernard EJ, Caussignac Y, Leduc R, Lougnarath R, ... ... Sarfati M, et al. CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNF. The Journal of Experimental Medicine. 210: 1251-63. PMID 23669395 DOI: 10.1084/Jem.20122037  0.617
2013 Wakahara K, Van VQ, Baba N, Bégin P, Rubio M, Delespesse G, Sarfati M. Basophils are recruited to inflamed lungs and exacerbate memory Th2 responses in mice and humans Allergy: European Journal of Allergy and Clinical Immunology. 68: 180-189. PMID 23205591 DOI: 10.1111/All.12072  0.574
2012 Wakahara K, Baba N, Van VQ, Bégin P, Rubio M, Ferraro P, Panzini B, Wassef R, Lahaie R, Caussignac Y, Tamaz R, Richard C, Soucy G, Delespesse G, Sarfati M. Human basophils interact with memory T cells to augment Th17 responses. Blood. 120: 4761-71. PMID 23071273 DOI: 10.1182/Blood-2012-04-424226  0.58
2012 Van VQ, Baba N, Rubio M, Wakahara K, Panzini B, Richard C, Soucy G, Franchimont D, Fortin G, Torres AC, Cabon L, Susin S, Sarfati M. CD47(low) status on CD4 effectors is necessary for the contraction/resolution of the immune response in humans and mice. Plos One. 7: e41972. PMID 22870271 DOI: 10.1371/Journal.Pone.0041972  0.571
2012 Baba N, Rubio M, Kenins L, Regairaz C, Woisetschlager M, Carballido JM, Sarfati M. The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naïve CD4(+) Th cells to promote the development of IL-22-secreting Th cells. Human Immunology. 73: 795-800. PMID 22609446 DOI: 10.1016/J.Humimm.2012.05.002  0.624
2012 Van VQ, Raymond M, Baba N, Rubio M, Wakahara K, Susin SA, Sarfati M. CD47(high) expression on CD4 effectors identifies functional long-lived memory T cell progenitors. Journal of Immunology (Baltimore, Md. : 1950). 188: 4249-55. PMID 22461697 DOI: 10.4049/Jimmunol.1102702  0.561
2011 Farso MC, Krantic S, Rubio M, Sarfati M, Quirion R. The retinoid, 6-[3-adamantyl-4-hydroxyphenyl]-2-napthalene carboxylic acid, controls proliferative, morphological, and inflammatory responses involved in microglial activation without cytotoxic effects. Neuroscience. 192: 172-84. PMID 21749910 DOI: 10.1016/j.neuroscience.2011.06.053  0.302
2011 Raymond M, Van VQ, Wakahara K, Rubio M, Sarfati M. Lung dendritic cells induce T(H)17 cells that produce T(H)2 cytokines, express GATA-3, and promote airway inflammation. The Journal of Allergy and Clinical Immunology. 128: 192-201.e6. PMID 21601259 DOI: 10.1016/J.Jaci.2011.04.029  0.399
2011 Quang Van V, Raymond M, Wakahara K, Rubio M, Sarfati M. Reprogramming in vivo th17 into th17/th2 by Sirp-α dendritic cells in the lungs Allergy, Asthma & Clinical Immunology. 7. DOI: 10.1186/1710-1492-7-S2-A27  0.443
2010 Raymond M, Van VQ, Rubio M, Welzenbach K, Sarfati M. Targeting SIRP-α protects from type 2-driven allergic airway inflammation. European Journal of Immunology. 40: 3510-8. PMID 21108471 DOI: 10.1002/Eji.201040797  0.517
2010 Baba N, Rubio M, Sarfati M. Interplay between CD45RA+ regulatory T cells and TNF-alpha in the regulation of human Th17 differentiation. International Immunology. 22: 237-44. PMID 20181653 DOI: 10.1093/Intimm/Dxp130  0.533
2009 Raymond M, Rubio M, Fortin G, Shalaby KH, Hammad H, Lambrecht BN, Sarfati M. Selective control of SIRP-alpha-positive airway dendritic cell trafficking through CD47 is critical for the development of T(H)2-mediated allergic inflammation. The Journal of Allergy and Clinical Immunology. 124: 1333-42.e1. PMID 19748659 DOI: 10.1016/J.Jaci.2009.07.021  0.512
2009 Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. Immunology. 128: e523-31. PMID 19740313 DOI: 10.1111/J.1365-2567.2008.03022.X  0.493
2009 Fortin G, Raymond M, Van VQ, Rubio M, Gautier P, Sarfati M, Franchimont D. A role for CD47 in the development of experimental colitis mediated by SIRPalpha+CD103- dendritic cells. The Journal of Experimental Medicine. 206: 1995-2011. PMID 19703989 DOI: 10.1084/Jem.20082805  0.55
2009 Bouguermouh S, Fortin G, Baba N, Rubio M, Sarfati M. CD28 co-stimulation down regulates Th17 development. Plos One. 4: e5087. PMID 19333372 DOI: 10.1371/Journal.Pone.0005087  0.66
2009 Barbier S, Chatre L, Bras M, Sancho P, Roué G, Virely C, Yuste VJ, Baudet S, Rubio M, Esquerda JE, Sarfati M, Merle-Béral H, Susin SA. Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton. Haematologica. 94: 507-17. PMID 19278964 DOI: 10.3324/Haematol.13690  0.371
2009 Fortin G, Yurchenko K, Collette C, Rubio M, Villani AC, Bitton A, Sarfati M, Franchimont D. L-carnitine, a diet component and organic cation transporter OCTN ligand, displays immunosuppressive properties and abrogates intestinal inflammation. Clinical and Experimental Immunology. 156: 161-71. PMID 19175620 DOI: 10.1111/J.1365-2249.2009.03879.X  0.574
2009 Guimont-Desrochers F, Beauchamp C, Chabot-Roy G, Dugas V, Hillhouse EE, Dusseault J, Langlois G, Gautier-Ethier P, Darwiche J, Sarfati M, Lesage S. Absence of CD47 in vivo influences thymic dendritic cell subset proportions but not negative selection of thymocytes. International Immunology. 21: 167-77. PMID 19147837 DOI: 10.1093/Intimm/Dxn135  0.56
2009 Merle-Béral H, Barbier S, Roué G, Bras M, Sarfati M, Susin SA. Caspase-independent type III PCD: A new means to modulate cell death in chronic lymphocytic leukemia Leukemia. 23: 974-977. PMID 19005478 DOI: 10.1038/Leu.2008.321  0.329
2008 Sarfati M, Fortin G, Raymond M, Susin S. CD47 in the immune response: role of thrombospondin and SIRP-alpha reverse signaling. Current Drug Targets. 9: 842-50. PMID 18855618 DOI: 10.2174/138945008785909310  0.532
2008 Van VQ, Darwiche J, Raymond M, Lesage S, Bouguermouh S, Rubio M, Sarfati M. Cutting edge: CD47 controls the in vivo proliferation and homeostasis of peripheral CD4+ CD25+ Foxp3+ regulatory T cells that express CD103. Journal of Immunology (Baltimore, Md. : 1950). 181: 5204-8. PMID 18832672 DOI: 10.4049/Jimmunol.181.8.5204  0.552
2008 Bouguermouh S, Van VQ, Martel J, Gautier P, Rubio M, Sarfati M. CD47 expression on T cell is a self-control negative regulator of type 1 immune response. Journal of Immunology (Baltimore, Md. : 1950). 180: 8073-82. PMID 18523271 DOI: 10.4049/Jimmunol.180.12.8073  0.608
2008 Baba N, Samson S, Bourdet-Sicard R, Rubio M, Sarfati M. Commensal bacteria trigger a full dendritic cell maturation program that promotes the expansion of non-Tr1 suppressor T cells. Journal of Leukocyte Biology. 84: 468-76. PMID 18511576 DOI: 10.1189/Jlb.0108017  0.549
2008 Fortin G, Raymond M, Rubio MA, Collette C, Villani A, Sarfati M, Franchimont D. 306 Deletion of CD47 Protects from Murine Experimental Crohn's Disease Gastroenterology. 134: A-43. DOI: 10.1016/S0016-5085(08)60209-7  0.438
2008 Fortin G, Rubio M, Franchimont D, Sarfati M. Sa.129. Altered Innate Cell Migration by CD47 Ablation Protects Mice from Experimental Colitis Clinical Immunology. 127: S123. DOI: 10.1016/J.Clim.2008.03.350  0.467
2008 Van VQ, Darwiche J, Raymond M, Lesage S, Bouguermouh S, Rubio M, Sarfati M. Sa.108. CD47 Controls the In Vivo Proliferation and Homeostasis of Peripheral CD4+CD25+ Foxp3+ Regulatory T Cells that Express CD103 Clinical Immunology. 127: S116. DOI: 10.1016/J.Clim.2008.03.329  0.536
2008 Raymond M, Rubio M, Sarfati M. Control of CD103- Myeloid DC Trafficking Through CD47 is Critical for the Development of TH2 Mediated Allergic Inflammation Clinical Immunology. 127: S29. DOI: 10.1016/J.Clim.2008.03.075  0.521
2008 Baba N, Rubio M, Sarfati M. OR.43. TNF-α Negatively Regulates the Differentiation of Human IL-17 and CCL20-producing T Helper Cells Clinical Immunology. 127: S19. DOI: 10.1016/J.Clim.2008.03.049  0.49
2007 Bras M, Yuste VJ, Roué G, Barbier S, Sancho P, Virely C, Rubio M, Baudet S, Esquerda JE, Merle-Béral H, Sarfati M, Susin SA. Drp1 mediates caspase-independent type III cell death in normal and leukemic cells. Molecular and Cellular Biology. 27: 7073-88. PMID 17682056 DOI: 10.1128/Mcb.02116-06  0.454
2007 Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, Chartier S, Paquette N, Ziegler SF, Sarfati M, Delespesse G. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. The Journal of Experimental Medicine. 204: 253-8. PMID 17242164 DOI: 10.1084/Jem.20062211  0.458
2007 Allakhverdi Z, Comeau M, Ziegler S, Sarfati M, Delespesse G. Thymic Stromal Lymphopoietin (TSLP) is Released by Human Epithelial Cells in Response to Microbes and Potently Activates Mast Cells Journal of Allergy and Clinical Immunology. 119: 523. DOI: 10.1016/J.Jaci.2006.12.627  0.358
2006 Braun D, Galibert L, Nakajima T, Saito H, Quang VV, Rubio M, Sarfati M. Semimature stage: a checkpoint in a dendritic cell maturation program that allows for functional reversion after signal-regulatory protein-alpha ligation and maturation signals. Journal of Immunology (Baltimore, Md. : 1950). 177: 8550-9. PMID 17142753 DOI: 10.4049/Jimmunol.177.12.8550  0.539
2006 Allakhverdi Z, Fitzpatrick D, Boisvert A, Baba N, Bouguermouh S, Sarfati M, Delespesse G. Expression of CD103 identifies human regulatory T-cell subsets. The Journal of Allergy and Clinical Immunology. 118: 1342-9. PMID 17137867 DOI: 10.1016/J.Jaci.2006.07.034  0.558
2006 Van VQ, Lesage S, Bouguermouh S, Gautier P, Rubio M, Levesque M, Nguyen S, Galibert L, Sarfati M. Expression of the self-marker CD47 on dendritic cells governs their trafficking to secondary lymphoid organs. The Embo Journal. 25: 5560-8. PMID 17093498 DOI: 10.1038/Sj.Emboj.7601415  0.506
2006 Grimbert P, Bouguermouh S, Baba N, Nakajima T, Allakhverdi Z, Braun D, Saito H, Rubio M, Delespesse G, Sarfati M. Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation. Journal of Immunology (Baltimore, Md. : 1950). 177: 3534-41. PMID 16951312 DOI: 10.4049/Jimmunol.177.6.3534  0.614
2006 Schäkel K, von Kietzell M, Hänsel A, Ebling A, Schulze L, Haase M, Semmler C, Sarfati M, Barclay AN, Randolph GJ, Meurer M, Rieber EP. Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes. Immunity. 24: 767-77. PMID 16782032 DOI: 10.1016/J.Immuni.2006.03.020  0.584
2006 Allakhverdi Z, Fitzpatrick D, Comeau M, Bouguermouh S, Sarfati M, Delespesse G. CD103 is a Marker of Human Suppressor Cells Journal of Allergy and Clinical Immunology. 117: S83. DOI: 10.1016/J.Jaci.2005.12.335  0.518
2006 Allakhverdi Z, Fitzpatrick D, Sarfati M, Delespesse G. OR.3. Coexpression of CD103 and CD25 Identifies Human Regulatory CD4+ T-Cells Clinical Immunology. 119: S5. DOI: 10.1016/J.Clim.2006.04.005  0.537
2003 Roué G, Bitton N, Yuste VJ, Montange T, Rubio M, Dessauge F, Delettre C, Merle-Béral H, Sarfati M, Susin SA. Mitochondrial dysfunction in CD47-mediated caspase-independent cell death: ROS production in the absence of cytochrome c and AIF release. Biochimie. 85: 741-6. PMID 14585540 DOI: 10.1016/S0300-9084(03)00129-9  0.496
2003 Doyen V, Rubio M, Braun D, Nakajima T, Abe J, Saito H, Delespesse G, Sarfati M. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. The Journal of Experimental Medicine. 198: 1277-83. PMID 14568985 DOI: 10.1084/Jem.20030705  0.56
2003 Sarfati M, Mateo V, Baudet S, Rubio M, Fernandez C, Davi F, Binet JL, Delic J, Merle-Beral H. Sildenafil and vardenafil, types 5 and 6 phosphodiesterase inhibitors, induce caspase-dependent apoptosis of B-chronic lymphocytic leukemia cells. Blood. 101: 265-9. PMID 12393651 DOI: 10.1182/blood-2002-01-0075  0.684
2002 Mateo V, Brown EJ, Biron G, Rubio M, Fischer A, Deist FL, Sarfati M. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood. 100: 2882-90. PMID 12351399 DOI: 10.1182/Blood-2001-12-0217  0.773
2001 Latour S, Tanaka H, Demeure C, Mateo V, Rubio M, Brown EJ, Maliszewski C, Lindberg FP, Oldenborg A, Ullrich A, Delespesse G, Sarfati M. Bidirectional negative regulation of human T and dendritic cells by CD47 and its cognate receptor signal-regulator protein-alpha: down-regulation of IL-12 responsiveness and inhibition of dendritic cell activation. Journal of Immunology (Baltimore, Md. : 1950). 167: 2547-54. PMID 11509594 DOI: 10.4049/Jimmunol.167.5.2547  0.812
2001 Avice MN, Rubio M, Sergerie M, Delespesse G, Sarfati M. Role of CD47 in the induction of human naive T cell anergy. Journal of Immunology (Baltimore, Md. : 1950). 167: 2459-68. PMID 11509584 DOI: 10.4049/Jimmunol.167.5.2459  0.825
2000 Avice MN, Rubio M, Sergerie M, Delespesse G, Sarfati M. CD47 ligation selectively inhibits the development of human naive T cells into Th1 effectors. Journal of Immunology (Baltimore, Md. : 1950). 165: 4624-31. PMID 11035105 DOI: 10.4049/Jimmunol.165.8.4624  0.824
2000 Tanaka H, Demeure CE, Rubio M, Delespesse G, Sarfati M. Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors: Role of stimulator/responder ratio Journal of Experimental Medicine. 192: 405-411. PMID 10934228 DOI: 10.1084/Jem.192.3.405  0.521
2000 Demeure CE, Tanaka H, Mateo V, Rubio M, Delespesse G, Sarfati M. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 164: 2193-9. PMID 10657674 DOI: 10.4049/Jimmunol.164.4.2193  0.821
1999 Mateo V, Lagneaux L, Bron D, Biron G, Armant M, Delespesse G, Sarfati M. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nature Medicine. 5: 1277-84. PMID 10545994 DOI: 10.1038/15233  0.751
1999 Armant M, Avice MN, Hermann P, Rubio M, Kiniwa M, Delespesse G, Sarfati M. CD47 ligation selectively downregulates human interleukin 12 production. The Journal of Experimental Medicine. 190: 1175-82. PMID 10523615 DOI: 10.1084/Jem.190.8.1175  0.813
1999 Delespesse G, Ohshima Y, Yang LP, Demeure C, Sarfati M. OX40-mediated cosignal enhances the maturation of naive human CD4+ T cells into high IL-4-producing effectors International Archives of Allergy and Immunology. 118: 384-386. PMID 10224454 DOI: 10.1159/000024143  0.63
1999 Ohshima Y, Yang LP, Avice MN, Kurimoto M, Nakajima T, Sergerie M, Demeure CE, Sarfati M, Delespesse G. Naive human CD4+ T cells are a major source of lymphotoxin alpha. Journal of Immunology (Baltimore, Md. : 1950). 162: 3790-4. PMID 10201895  0.808
1999 Avice MN, Sarfati M, Triebel F, Delespesse G, Demeure CE. Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 162: 2748-53. PMID 10072520  0.798
1999 Hermann P, Armant M, Brown E, Rubio M, Ishihara H, Ulrich D, Caspary RG, Lindberg FP, Armitage R, Maliszewski C, Delespesse G, Sarfati M. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. The Journal of Cell Biology. 144: 767-75. PMID 10037797 DOI: 10.1083/jcb.144.4.767  0.448
1998 Avice MN, Demeure CE, Delespesse G, Rubio M, Armant M, Sarfati M. IL-15 promotes IL-12 production by human monocytes via T cell-dependent contact and may contribute to IL-12-mediated IFN-gamma secretion by CD4+ T cells in the absence of TCR ligation. Journal of Immunology (Baltimore, Md. : 1950). 161: 3408-15. PMID 9759858  0.822
1998 Hermann P, Rubio M, Nakajima T, Delespesse G, Sarfati M. IFN-α priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL- 12p70, CD80, and MHC class I expression Journal of Immunology. 161: 2011-2018. PMID 9712074  0.36
1998 Delespesse G, Yang LP, Ohshima Y, Demeure C, Shu U, Byun DG, Sarfati M. Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors Vaccine. 16: 1415-1419. PMID 9711781 DOI: 10.1016/S0264-410X(98)00101-7  0.662
1998 Mateo V, Lagneaux L, Bron D, Sarfati M. Induction of apoptosis in B-cells from chronic lymphocytic leukemia (B-CLLS) by CD47 Faseb Journal. 12.  0.765
1998 Armant M, Avice MN, Rubio M, Delespesse G, Sarfati M. CD47 negatively regulates IL-12 production Faseb Journal. 12.  0.81
1998 Demeure CE, Avice MN, Sarfati M, Delespesse G, Triebel F. LAG-3, the second MHC class II ligand expressed on activated T cells, induces TNFα and costimulates IL-12 production by monocytes Faseb Journal. 12.  0.802
1997 Joseph M, Gounni AS, Kusnierz JP, Vorng H, Sarfati M, Kinet JP, Tonnel AB, Capron A, Capron M. Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors European Journal of Immunology. 27: 2212-2218. PMID 9341761 DOI: 10.1002/Eji.1830270914  0.388
1997 Delespesse G, Ohshima Y, Shu U, Yang L, Demeure C, Wu C, Byun D, Sarfati M. Differentiation of naive human CD4 T cells into TH2/TH1 effectors Allergology International. 46: 63-72. DOI: 10.2332/Allergolint.46.63  0.614
1996 Vezzio N, Sarfati M, Yang LP, Demeure CE, Delespesse G. Human T(h)2-like cell clones induce IL-12 production by dendritic cells and may express several cytokine profiles International Immunology. 8: 1963-1970. PMID 8982781 DOI: 10.1093/Intimm/8.12.1963  0.594
1996 Delespesse G, Yang LP, Shu U, Byun DG, Demeure CE, Ohshima Y, Wu CY, Sarfati M. Role of interleukin-12 in the maturation of naive human CD4 T cells Annals of the New York Academy of Sciences. 795: 196-201. PMID 8958930 DOI: 10.1111/J.1749-6632.1996.Tb52668.X  0.569
1996 Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet JL, Merle-Beral H, Bron D. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia Blood. 88: 4259-4264. PMID 8943862 DOI: 10.1182/Blood.V88.11.4259.Bloodjournal88114259  0.309
1996 Armant M, Armitage R, Boiani N, Delespesse G, Sarfati M. Functional CD40 ligand expression on T lymphocytes in the absence of T cell receptor engagement: Involvement in interleukin-2 induced interleukin-12 and interferon-γ production European Journal of Immunology. 26: 1430-1434. PMID 8766543 DOI: 10.1002/Eji.1830260705  0.639
1996 Hermann P, Armitage R, Sarfati M. CD40 triggering and ifnγ synergized with soluble cd23 (scd23) to trigger tnfα release by human monocytes Faseb Journal. 10.  0.517
1995 Fournier S, Yang LP, Delespesse G, Rubio M, Biron G, Sarfati M. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia British Journal of Haematology. 89: 373-379. PMID 7873388  0.52
1995 Paul-Eugene N, Kolb JP, Sarfati M, Arock M, Ouaaz F, Debre P, Mossalayi DM, Dugas B. Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism Journal of Leukocyte Biology. 57: 160-167. PMID 7829968 DOI: 10.1002/Jlb.57.1.160  0.487
1995 Armant M, Delespesse G, Sarfati M. IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression Immunology. 85: 331-337. PMID 7642225  0.457
1995 Paul-Eugène N, Mossalayi D, Sarfati M, Yamaoka K, Aubry JP, Bonnefoy JY, Dugas B, Kolb JP. Evidence for a Role of Fcε{lunate}RII/CD23 in the IL-4-Induced Nitric Oxide Production by Normal Human Mononuclear Phagocytes Cellular Immunology. 163: 314-318. PMID 7606802 DOI: 10.1006/cimm.1995.1132  0.489
1995 Armant M, Rubio M, Delespesse G, Sarfati M. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells Journal of Immunology. 155: 4868-4875. PMID 7594490  0.588
1994 Fournier S, Rubio M, Delespesse G, Sarfati M. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B- cell proliferation Blood. 84: 1881-1886. PMID 8080994 DOI: 10.1182/Blood.V84.6.1881.1881  0.533
1994 Armant M, Ishihara H, Rubio M, Delespesse G, Sarfati M. Regulation of cytokine production by soluble CD23: Costimulation of interferon γ secretion and triggering of tumor necrosis factor α release Journal of Experimental Medicine. 180: 1005-1011. PMID 8064221 DOI: 10.1084/Jem.180.3.1005  0.504
1993 Kolb JP, Abadie A, Paul-Eugene N, Capron M, Sarfati M, Dugas B, Delespesse G. Ligation of CD23 Triggers Cyclic AMP Generation in Human B Lymphocytes Journal of Immunology. 150: 4798-4809. PMID 8388420  0.516
1993 Sarfati M. Interleukin-4 and the two isoforms of CD23 antigen: their possible contribution to the physiopathology of chronic lymphocytic leukemia disease Nouvelle Revue Francaise D"Hematologie. 35: 109-113. PMID 8332446  0.456
1993 Sarfati M. CD23 and chronic lymphocytic leukemia Blood Cells. 19: 591-596. PMID 8018941  0.445
1992 Fournier S, Jackson J, Kumar A, King T, Sharma S, Biron G, Rubio M, Delespesse G, Sarfati M. Low-molecular weight B cell growth factor (BCGF-12KD) as an autocrine growth factor in B cell chronic lymphocytic leukemia European Journal of Immunology. 22: 1927-1930. PMID 1623931 DOI: 10.1002/Eji.1830220737  0.343
1992 Martel-Pelletier J, McCollum R, DiBattista J, Faure MP, Chin JA, Fournier S, Sarfati M, Pelletier JP. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes: Identification as the type I receptor and analysis of binding kinetics and biologic function Arthritis and Rheumatism. 35: 530-540. PMID 1533521 DOI: 10.1002/art.1780350507  0.38
1992 Fournier S, Delespesse G, Rubio M, Biron G, Sarfati M. CD23 antigen regulation and signaling in chronic lymphocytic leukemia Journal of Clinical Investigation. 89: 1312-1321. PMID 1532590  0.587
1992 Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression Journal of Experimental Medicine. 176: 1319-1326. PMID 1402678 DOI: 10.1084/Jem.176.5.1319  0.522
1992 Sarfati M, Bettler B, Letellier M, Fournier S, Rubio-Trujillo M, Hofstetter H, Delespesse G. Native and recombinant soluble CD23 fragments with IgE suppressive activity. Immunology. 76: 662-7. PMID 1398755  0.453
1992 Mossalayi MD, Arock M, Delespesse G, Hofstetter H, Bettler B, Dalloul AH, Kilchherr E, Quaaz F, Debré P, Sarfati M. Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site. The Embo Journal. 11: 4323-8. PMID 1385115 DOI: 10.1002/J.1460-2075.1992.Tb05531.X  0.535
1992 Dancescu M, Wu C, Rubio M, Delespesse G, Sarfati M. IL-4 induces conformational change of CD20 antigen via a protein kinase C-independent pathway: Antagonistic effect of anti-CD40 monoclonal antibody Journal of Immunology. 148: 2411-2416. PMID 1373168  0.578
1992 Paul-Eugene N, Kolb JP, Abadie A, Gordon J, Delespesse G, Sarfati M, Mencia-Huerta JM, Braquet P, Dugas B. Ligation of CD23 triggers camp generation and release of inflammatory mediators in human monocytes Journal of Immunology. 149: 3066-3071. PMID 1328391  0.484
1992 Sarfati M, Fournier S, Wu CY, Delespesse G. Expression, regulation and function of human FcεRII (CD23) antigen Immunologic Research. 11: 260-272. PMID 1287120 DOI: 10.1007/Bf02919132  0.55
1991 Fournier S, Tran ID, Suter U, Biron G, Delespesse G, Sarfati M. The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts. Leukemia Research. 15: 609-18. PMID 1830631 DOI: 10.1016/0145-2126(91)90030-W  0.576
1991 Delespesse G, Sarfati M. An update on human CD23 (FcεRII). FcεRII and IgE-BFs (soluble CD23) play an essential role in the regulation of human IgE synthesis Clinical and Experimental Allergy, Supplement. 21: 153-161. PMID 1827751  0.379
1991 Wu CY, Sarfati M, Heusser C, Fournier S, Rubio-Trujillo M, Peleman R, Delespesse G. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes Journal of Clinical Investigation. 87: 870-877. PMID 1825666  0.569
1991 Luo H, Rubio M, Biron G, Delespesse G, Sarfati M. Antiproliferative effect of interleukin-4 in B chronic lymphocytic leukemia Journal of Immunotherapy. 10: 418-425. PMID 1768675 DOI: 10.1097/00002371-199112000-00005  0.508
1991 Kolb JP, Genot E, Poggioli J, Abadie A, Sarfati M, Delespesse G, Dugas B. Transduction through CD23: different signalling pathways in human B cells and monocytes Monographs in Allergy. 29: 135-155. PMID 1661375  0.365
1991 Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfati M, Hofstetter H, Kilcherr E, Debre P, Dalloul A. Expression, structure, and function of the CD23 antigen. Advances in Immunology. 49: 149-91. PMID 1649548 DOI: 10.1016/S0065-2776(08)60776-2  0.519
1990 Kolb JP, Renard D, Dugas B, Genot E, Petit-Koskas E, Sarfati M, Delespesse G, Poggioli J. Monoclonal anti-CD23 antibodies induce a rise in [Ca2+]i and polyphosphoinositide hydrolysis in human activated B cells Involvement of a Gp protein Journal of Immunology. 145: 429-437. PMID 2164062  0.423
1990 Fargeas C, Wu C, Luo H, Sarfati M, Delespesse G, Wu J. 1,25(OH)2 vitamin D3 inhibits the CD23 gene expression by human peripheral blood monocytes Journal of Immunology. 145: 4053-4058. PMID 2147934  0.382
1990 Delespesse G, Sarfati M. IgE-binding factors (soluble CD23) and IgE regulation Research in Immunology. 141: 75-77. PMID 2140615 DOI: 10.1016/0923-2494(90)90105-8  0.339
1990 Mossalayi MD, Arock M, Bertho JM, Blanc C, Dalloul AH, Hofstetter H, Sarfati M, Delespesse G, Debré P. Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23 Blood. 75: 1924-1927. PMID 2140059  0.512
1990 Mossalayi MD, Lecron JC, Dalloul AH, Sarfati M, Bertho JM, Hofstetter H, Delespesse G, Debre P. Soluble CD23 (FcεRII) and interleukin 1 synergistically induce early human thymocyte maturation Journal of Experimental Medicine. 171: 959-964. PMID 2137858 DOI: 10.1084/jem.171.3.959  0.431
1990 Sarfati M, Fournier S, Christoffersen M, Biron G. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia Leukemia Research. 14: 47-55. PMID 2137545 DOI: 10.1016/0145-2126(90)90145-Y  0.591
1989 Letellier M, Sarfati M, Delespesse G. Mechanisms of formation of IgE-binding factors (soluble CD23)-I. Fcε{lunate} R II bearing B cells generate IgE-binding factors of different molecular weights Molecular Immunology. 26: 1105-1112. PMID 2534424 DOI: 10.1016/0161-5890(89)90054-0  0.344
1989 Delespesse GJT, Hofsietter H, Sarfati M. Low-affinity receptor for IgE (FcERII, CD23) and its soluble fragments International Archives of Allergy and Immunology. 90: 41-44. PMID 2533179 DOI: 10.1159/000235074  0.592
1989 Genot E, Sarfati M, Sigaux F, Petit-Koskas E, Billard C, Mathiot C, Falcoff E, Delespesse G, Kolb JP. Effect of interferon-α on the expression and release of the CD23 molecule in hairy cell leukemia Blood. 74: 2455-2463. PMID 2529929  0.404
1989 Delespesse G, Sarfati M, Hofstetter H, Frost H, Kilchherr E, Suter U. Human Fc epsilon R II and IgE-binding factors. International Archives of Allergy and Applied Immunology. 88: 18-22. PMID 2523355 DOI: 10.1159/000234741  0.349
1989 Delespesse G, Sarfati M, Peleman R. Influence of recombinant IL-4, IFN-α, and IFN-γ on the production of human IgE-binding factor (soluble CD23) Journal of Immunology. 142: 134-138. PMID 2521231  0.491
1989 Sarfati M, Luo H, Delespesse G. IgE synthesis by chronic lymphocytic leukemia cells Journal of Experimental Medicine. 170: 1775-1780. PMID 2478656 DOI: 10.1084/Jem.170.5.1775  0.588
1989 Delespesse G, Sarfati M, Hofstetter H. Human IgE-binding factors Trends in Immunology. 10: 159-164. DOI: 10.1016/0167-5699(89)90173-4  0.399
1988 Delespesse G, Sarfati M. IgE-binding factors: Their possible role in the regulation of IgE synthesis La Ricerca in Clinica E in Laboratorio. 18: 75-92. PMID 3062750 DOI: 10.1007/BF02918876  0.35
1988 Sarfati M, Bron D, Lagneaux L, Fonteyn C, Frost H, Delespesse G. Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia Blood. 71: 94-98. PMID 2961381 DOI: 10.1182/Blood.V71.1.94.Bloodjournal71194  0.371
1987 Delespesse G, Sarfati M, Rubio-Trujillo M. In vitro production of IgE-binding factors by human mononuclear cells Immunology. 60: 103-110. PMID 3493203  0.324
1986 Delespesse G, Sarfati M, Rubio-Trujillo M, Wolowiec T. IgE receptors on human lymphocytes. II. Detection of cells bearing IgE receptors in unstimulated mononuclear cells by means of a monoclonal antibody European Journal of Immunology. 16: 815-821. PMID 2941309  0.308
Show low-probability matches.